Table 1. Lack of Concordance on YY1 Overexpression Levels in Prostate Cancer in Various Datasets (2001-2012).

Year	Oncomine Name	# of Carcinomas	Prostate Cancer vs. Normal Prostate
2001	Welsh Prostate [84]	25	Underexpression, p = 0.009
2002	Singh Prostate [83]	52	Overexpression, p = 0.00004
2002	Luo Prostate [85]	15	No change, p = 0.090 (NS*)
2002	LaTulippe Prostate [86]	23	No change, p = 0.141 (NS)
2003	Vanaja Prostate [87]	27	Overexpression, p = 0.004
2004	Yu Prostate [80]	65	No change, p = 0.022
2004	La Pointe Prostate [88]	54	No change, p = 0.163 (NS)
2005	Varambally Prostate [41]	7	No change, p = 0.176 (NS)
2006	Bandyopadhyay Prostate (Liu)[89]	44	No change, p = 0.098 (NS)
2007	Tomlins Prostate [90]	26	Overexpression, p = 0.016
2008	Ambs Prostate (Wallace)[81]	69	Underexpression, p = 0.0007
2009	Arredouani Prostate [91]	44	No change, p = 0.032
2010	Taylor Prostate [82]	131	No change, p = 0.578 (NS)
2012	Grasso Prostate [92]	59	No change, p = 0.612 (NS)

^*NS = Not Significant